488 related articles for article (PubMed ID: 17488762)
1. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
Egami T; Egami K; Tanoue A
Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
[TBL] [Abstract][Full Text] [Related]
2. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
[TBL] [Abstract][Full Text] [Related]
3. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
4. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
5. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
[TBL] [Abstract][Full Text] [Related]
6. Waning immunity and subclinical measles infections in England.
Glass K; Grenfell BT
Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
[TBL] [Abstract][Full Text] [Related]
7. Immunological response to measles vaccination in poor communities.
Bhaskaram P; Madhusudan J; Radhrakrishna KV; Raj S
Hum Nutr Clin Nutr; 1986 Jul; 40(4):295-9. PubMed ID: 3744889
[TBL] [Abstract][Full Text] [Related]
8. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
9. Low seroconversion rates to measles vaccine among children in Nigeria.
Adu FD; Akinwolere OA; Tomori O; Uche LN
Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
12. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
[TBL] [Abstract][Full Text] [Related]
13. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
Liu BY; Feng ZX; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
[TBL] [Abstract][Full Text] [Related]
14. [Study on the immunization effect of measles vaccine by capture-EIA].
Fang H
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
[TBL] [Abstract][Full Text] [Related]
15. Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria.
Omilabu SA; Oyefolu AO; Ojo OO; Audu RA
Afr J Med Med Sci; 1999; 28(3-4):209-12. PubMed ID: 11205835
[TBL] [Abstract][Full Text] [Related]
16. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
Lin M
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
[TBL] [Abstract][Full Text] [Related]
17. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
al-Attar I; Reisman J; Muehlmann M; McIntosh K
Pediatr Infect Dis J; 1995 Feb; 14(2):149-51. PubMed ID: 7746699
[No Abstract] [Full Text] [Related]
18. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
19. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
[TBL] [Abstract][Full Text] [Related]
20. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
abu Eldan J; Borćić B; Smerdel S
Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]